Indeed, SRGAP2 itself shows no changes in its comparatively higher expression (with FAM72A) with slight differences in promoter methylation of SRGAP2 in breast, liver, lung, and uterine cancers (Figure 8). The gene discussed is SRGAP2; the disease is uterine cancer.